See up to 3 months of XGN. The 7-day demo opens the 1M and 3M ranges and puts XGN on your watchlist.
Start 7-day demoLatest XGN insider trades
Jorey Chernett - 10% OwnerOpen-market purchase$104K- John Aballi
About EXAGEN INC. (XGN)
EXAGEN INC. files with the SEC under CIK 0001274737 and is classified as medical laboratories. We track it alongside the rest of the Health Care sector.
XGN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 14,000 | $104K |
| Open-market sale | 2 | 54,908 | $419K |
| Grant or award | 5 | 170,271 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
XGN insider transactions (Form 4)
3025 Form 4 filings on record, the earliest from Nov 18, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tina Susan Nova - Director | Grant or award | Stock Option(right to buy) | 56,200 | $0.00 | - | |
| Jorey Chernett - 10% Owner | Open-market purchase | Common Stock | 14,000 | $7.46 footnote F1 | $104K | |
| ||||||
| John Aballi - Officer | Open-market sale | Common Stock | 34,294 | $7.87 | $270K | |
| Jeffrey G. Black - Officer | Open-market sale | Common Stock | 20,614 | $7.22 | $149K | |
| Jeffrey G. Black - Officer | Grant or award | Common Stock | 1,571 | $3.02 footnote F3 | $5K | |
| ||||||
| Bruce C. Robertson - Director | Grant or award | Stock Option(right to buy) | 37,500 | $0.00 | - | |
| Bruce C. Robertson - Director | Grant or award | Stock Option(right to buy) | 37,500 | $0.00 | - | |
| Paul Kim - Director | Grant or award | Stock Option(right to buy) | 37,500 | $0.00 | - | |
| Scott D. Kahn - Director | Grant or award | Stock Option(right to buy) | 37,500 | $0.00 | - | |
| Chas McKhann - Director | Grant or award | Stock Option(right to buy) | 37,500 | $0.00 | - | |
 Frank Stokes - Director | Grant or award | Stock Option(right to buy) | 37,500 | $0.00 | - | |
| Jeffrey G. Black - Officer | Grant or award | Common Stock | 75,000 | $3.16 | $237K | |
| Jeffrey G. Black - Officer | Grant or award | Common Stock | 1,511 footnote F3 | $3.08 | $5K | |
| Jeffrey G. Black - Officer | Grant or award | Stock Option(right to buy) | 50,000 | $3.16 | $158K | |
| ||||||
| John Aballi - Officer | Grant or award | Common Stock | 150,000 footnote F1 | $0.00 | - | |
| John Aballi - Officer | Grant or award | Stock Option(right to buy) | 100,000 | $3.16 | $316K | |
| ||||||
| John Aballi - Officer | Grant or award | Common Stock | 2,535 footnote F3 | $3.08 | $8K | |
| John Aballi - Officer | Open-market sale | Common Stock | 15,698 | $3.62 | $57K | |
| ||||||
| John Aballi - Officer | Open-market sale | Common Stock | 11,430 | $3.61 | $41K | |
| Jeffrey G. Black - Officer | Open-market sale | Common Stock | 1,584 | $3.61 | $6K | |
| John Aballi - Officer | Open-market sale | Common Stock | 31,787 | $11.82 | $376K | |
| Jeffrey G. Black - Officer | Open-market sale | Common Stock | 20,466 | $9.79 | $200K | |
| Frank Stokes - Director | Grant or award | Stock Option(right to buy) | 9,000 | $0.00 | - | |
| Ana Hooker - Director | Grant or award | Stock Option(right to buy) | 9,000 | $0.00 | - | |
| Tina Susan Nova - Director | Grant or award | Stock Option(right to buy) | 13,500 | $0.00 | - | |
| Paul Kim - Director | Grant or award | Stock Option(right to buy) | 9,000 | $0.00 | - | |
| Scott D. Kahn - Director | Grant or award | Stock Option(right to buy) | 9,000 | $0.00 | - | |
| NMSIC Co-Investment Fund, L.P. | Open-market sale | Common Stock | 200,000 | $3.30 | $660K | |
| Jeffrey G. Black - Officer | Open-market purchase | Common Stock | 22,298 | $2.98 | $66K | |
| John Aballi - Officer | Open-market purchase | Common Stock | 24,305 | $2.81 | $68K | |
Item 2.02, 9.01
Item 5.07
Item 2.02, 9.01
Item 5.02, 9.01
XGN insider trading FAQ
What is the latest insider trade for XGN?
EXAGEN INC. (XGN) had 7 insider filings in the last 90 days, with the most recent on 2 November 2026. The full record for XGN runs to 25 Form 4 filings, the earliest from 18 November 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying XGN stock?
1 insider purchase of XGN was filed in the last 90 days, totaling $104K.
How many insiders are selling XGN stock?
2 insider sales of XGN were filed in the last 90 days, totaling $419K.
Where can I see XGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects XGN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Tina Susan Nova view on EDGAR
- - Jorey Chernett view on EDGAR
- - John Aballi view on EDGAR
- - Jeffrey G. Black view on EDGAR
- - Bruce C. Robertson view on EDGAR
- - Bruce C. Robertson view on EDGAR
- - Paul Kim view on EDGAR
- - Scott D. Kahn view on EDGAR
- - Chas McKhann view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where XGN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow XGN with a 7-day demo
- XGN on your watchlist
- Every XGN Form 4 filing on record
- Up to 3 months of XGN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
